Back to Search
Start Over
Efficacy of the combination of rituximab-bendamustine as a second-line treatment in patients with follicular lymphoma who progress after immunochemotherapy: a phase II trial of the Spanish Lymphoma Oncology Group
- Source :
- Leukemia & Lymphoma. 60:1576-1579
- Publication Year :
- 2018
- Publisher :
- Informa UK Limited, 2018.
-
Abstract
- Bendamustine is a drug widely used in the treatment of follicular lymphoma. Although it was initially approved as monotherapy in patients refractory to rituximab [1], better results were obtained w...
- Subjects :
- Oncology
Bendamustine
Cancer Research
medicine.medical_specialty
business.industry
Follicular lymphoma
Hematology
medicine.disease
Lymphoma
Clinical trial
03 medical and health sciences
0302 clinical medicine
Refractory
immune system diseases
hemic and lymphatic diseases
030220 oncology & carcinogenesis
Internal medicine
Medicine
Rituximab
Progression-free survival
business
Prospective cohort study
030215 immunology
medicine.drug
Subjects
Details
- ISSN :
- 10292403 and 10428194
- Volume :
- 60
- Database :
- OpenAIRE
- Journal :
- Leukemia & Lymphoma
- Accession number :
- edsair.doi...........2d58ee0ec692c9694f082990415bc9d5